Delivery Order SPE2DB20D2104-SPE2DB25FMTEM

Award Date 6/12/25
Potential Completion Date 6/13/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,638.20 contract is for the delivery of Januvia 50 mg tablets, a medication used to treat type 2 diabetes. The contract has a completion date of June 17, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Januvia 50 mg tablets, a medication used to treat type 2 diabetes. The award has a ceiling value of $1,091.46 and a completion date of May 6, 2025. This contract is not set-aside and is a firm fixed-price, delivery order type. Amerisourcebergen Drug Corp is the prime contractor and holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Januvia 100 mg tablets, a prescription medication used to treat type 2 diabetes. The contract has a firm fixed price of $1,455.28 and a period of performance through April 30, 2025. This contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,455.28 firm fixed-price contract is for the supply of Januvia 50 mg tablets, a medication used to treat diabetes. The contract has a period of performance through May 29, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Januvia 50 mg tablets, a medication used to treat diabetes. The contract has a ceiling value of $1,571.19 and is a firm fixed-price delivery order with a completion date of June 13, 2025. The contract is not set-aside and is open to full and open competition....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Januvia 50 mg tablets, a medication used to treat type 2 diabetes. The contract is a firm fixed-price delivery order with a ceiling value of $2,264.76 and a period of performance through April 24, 2025. This contract is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a larger...
This is a $1,468.43 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Januvia 50 mg tablets, a medication used to treat type 2 diabetes. The delivery order has an ultimate completion date of May 2, 2025 and is not set aside for a specific business type. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $33,867.08 firm fixed-price contract is for the supply of Januvia 100 mg tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of April 29, 2025 and is not set aside. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Januvia 50 mg tablets, a diabetes medication, with a ceiling value of $1,109.94 and a performance period ending on April 18, 2025. The contract is not set aside and is a firm fixed-price delivery order. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUVIA 50 MG tablets, a medication used to treat type 2 diabetes. The contract has a ceiling value of $6,366.85 and a period of performance through April 1, 2025. It is a firm fixed-price contract, and there is no set-aside designation indicated. AmerisourceBergen holds a...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMTEM
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Januvia 50 mg tablets, a medication used to treat type 2 diabetes. The contract has a firm fixed-price pricing type, a ceiling value of $1,128.42, and a completion date of June 13, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 9/11/25, 10:58 AM